{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:12:20Z","timestamp":1787170340080,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK 35816"],"award-info":[{"award-number":["DK 35816"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL49546"],"award-info":[{"award-number":["R01 HL49546"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.amjcard.2003.10.009","type":"journal-article","created":{"date-parts":[[2004,1,28]],"date-time":"2004-01-28T12:48:51Z","timestamp":1075294131000},"page":"307-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)"],"prefix":"10.1016","volume":"93","author":[{"given":"Xue-Qiao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh S","family":"Morse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice A","family":"Dowdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Heise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"DeAngelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Frohlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Chait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J","family":"Albers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.Greg","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2003.10.009_BIB1","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa011090","article-title":"Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease","volume":"345","author":"Brown","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0002-8223(02)90031-3","article-title":"American Diabetes Association position statement","volume":"102","year":"2002","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB3","unstructured":"Jacobs SM. Minimum dose of crystalline niacin necessary to provoke a cutaneous flush: independent study in Medical Science Project. Seattle: University of Washington School of Medicine, January 18, 1999"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1067\/mhj.2002.120158","article-title":"Effect of very-low-dose niacin on high-density lipoprotein in patients undergoing long-term statin therapy","volume":"143","author":"Wink","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJM198801073180110","article-title":"Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin","volume":"318","author":"Norman","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB6","doi-asserted-by":"crossref","first-page":"597","DOI":"10.7326\/0003-4819-109-7-597_2","article-title":"Lovastatin, nicotinic acid, and rhabdomyolysis","volume":"109","author":"Reaven","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB7","unstructured":"Merck & Company. Product information for Mevacor (lovastatin). Physician's Desk Reference. Montvale, NJ: Medical Economics Company, 1996:1701"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB8","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0002-9149(98)00955-2","article-title":"Treatment of hyperlipidemia with combined niacin-statin regimens","volume":"82","author":"Guyton","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0002-9149(01)02338-4","article-title":"Long-term safety and efficacy of a once-daily niacin\/lovastatin formulation for patients with dyslipidemia","volume":"89","author":"Kashyap","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB10","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.1975.03240160024021","article-title":"Clofibrate and niacin in coronary heart disease","volume":"231","year":"1975","journal-title":"JAMA"},{"issue":"suppl 3","key":"10.1016\/j.amjcard.2003.10.009_BIB11","first-page":"100","article-title":"Adult treatment guidelines","volume":"36","year":"1988","journal-title":"Drugs"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB12","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jama.1961.03040340010003","article-title":"Nicotinic acid treatment of hypercholesterolemia","volume":"177","author":"Christensen","year":"1961","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0002-9343(61)90221-2","article-title":"Hypercholesterolemia and nicotinic acid","volume":"31","author":"Berge","year":"1961","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB14","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1001\/archinte.1988.00380110121025","article-title":"Effect of low-dose niacin on high density lipoprotein cholesterol and total cholesterol\/high density lipoprotein cholesterol ratio","volume":"148","author":"Luria","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB15","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1001\/archinte.1991.00400070172024","article-title":"Niacin revisited","volume":"151","author":"Keenan","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB16","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0002-9149(00)00703-7","article-title":"Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia","volume":"85","author":"Goldberg","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB17","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jama.1994.03510330050033","article-title":"A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients","volume":"271","author":"McKenney","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB18","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/0026-0495(85)90092-7","article-title":"Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects","volume":"34","author":"Knopp","year":"1985","journal-title":"Metabolism"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.7326\/0003-4819-121-4-199408150-00003","article-title":"Efficacy and safety of controlled-release niacin in dyslipoproteinemic veterans","volume":"121","author":"Gray","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0002-9343(92)90018-7","article-title":"Hepatic toxicity of unmodified and time-release preparations of niacin","volume":"92","author":"Rader","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB21","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of The third Report of The National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB22","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1161\/01.CIR.100.10.1134","article-title":"Diabetes and cardiovascular disease","volume":"100","author":"Grundy","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB23","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jama.284.10.1263","article-title":"Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease","volume":"284","author":"Elam","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB24","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/archinte.162.14.1568","article-title":"Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes","volume":"162","author":"Grundy","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB25","unstructured":"Morse JS, Brown BG, Zhao X-Q, Fisher L, Chait A, Dowdy A, Serafini L, Huss-Frechette E, DeAngelis D, Frohllich, Albers JJ: Niacin plus simvastatin protect against atherosclerosis progression and clinical events in CAD patients with low HDLc and diabetes mellitus or impaired fasting glucose. J Am Coll Cardiol 2001;37 (suppl A):1A\u2013648A"},{"key":"10.1016\/j.amjcard.2003.10.009_BIB26","first-page":"II-636","article-title":"Niacin decrreases mypcardial infarction and total mortality in patients with impaired fasting glucose or glucose intolerance","volume":"106","author":"Canner","year":"2002","journal-title":"Circulation"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914903014851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914903014851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:00:22Z","timestamp":1762077622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914903014851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0002914903014851"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2003.10.009","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2003.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Excerpta Medica Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}